From Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug:

white-human-brain-picture-id627014070

white-human-brain-picture-id627014070—

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Sponsored · Webinar
Aug. 19 – Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation
This new paradigm may well define a next dimension of precision medicine
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!